BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics
Amount Raised
$170 Million
Round Type
Series D
RichmondBiotechnologyHealth CareTherapeuticsInvestors
Description
BioAge Labs announced a $170 million oversubscribed Series D financing round led by Sofinnova Investments, with participation from a top-tier syndicate of investors and pharma companies. The funding will be used to support Phase 2 clinical development of BioAge’s lead compound azelaprag, an oral apelin receptor agonist, in combination with Lilly's Zepbound (tirzepatide) and other incretins for the treatment of obesity. The studies with Zepbound are expected to begin in mid-2024, in collaboration with Eli Lilly’s Chorus organization. Azelaprag is an oral drug with the potential to significantly increase weight loss and improve body composition when combined with any incretin
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as BioAge Labs that raised within 45 days of this round, from Fundz verified event records.
- Vaccinex raised $1.8M (Seed) on March 29, 2024.
- Vaccinex raised $1.2M (Seed) on March 28, 2024.
- Avalo Therapeutics raised $131M on March 27, 2024.
- AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
- Nouscom raised $76M (Series C) on March 21, 2024.
- Enliven Therapeutics raised $90M on March 21, 2024.
Who to call at BioAge Labs, and when
A new round usually means BioAge Labs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioAge Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioAge Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioAge Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioAge Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioAge Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.